Estée Lauder and Puig have confirmed they are in discussions over a potential merger that could create a luxury beauty group with a combined market capitalisation of around $40 billion, bringing together a portfolio of global brands spanning skincare, cosmetics, and fragrances.
The companies said on March 23 that talks are ongoing, confirming earlier media reports.
The proposed transaction could involve a mix of cash and stock, The Wall Street Journal has reported, but both sides cautioned there is no certainty a deal will be reached.
The potential tie-up would unite brands such as Tom Ford, Carolina Herrera, Rabanne, and Clinique under a single umbrella, significantly reshaping the competitive landscape in the premium beauty segment.
However, while Puig investors welcomed the confirmation, with the share price closing 13% higher on Tuesday, Shares of Estée Lauder fell more than 10% following the announcement.
Scale of the deal, integration demands a challenge
Analysts said the scale of the transaction could pose challenges for a company already navigating a turnaround.
Dan Coatsworth, head of markets at AJ Bell, said that while the deal may appear attractive on paper, integrating two large businesses is rarely straightforward.
“A takeover of Puig is an interesting proposition, but history suggests that bolting two companies together is not a guaranteed recipe for success,” he said, citing differences in culture as an example.
Morningstar analyst Dan Su echoed similar concerns, warning that the size of the deal and integration demands could distract management at a critical time for Estée Lauder.
“We see challenges from the deal size and its potential to distract Estee’s management amid a turnaround … We doubt that management can execute this plan efficiently while integrating Puig,” Su said.
Valuation and control dynamics in focus
Questions have also emerged around whether Estée Lauder could end up overpaying for Puig, which has a market value of roughly $10 billion.
The Lauder family, which controls more than 80% of voting rights in the US company, may see strategic merit in diversifying away from China, where demand has been uneven.
Puig, by contrast, has a stronger presence in fragrances, a segment that has shown resilience even as broader beauty demand has fluctuated.
Around three-quarters of Puig’s revenue comes from fragrances, and it is expected to deliver higher operating margins than Estée Lauder.
However, Puig’s controlling family, which holds over 90% of voting power, is unlikely to agree to a sale at a significant discount, as not only are there other possible bidders like L’Oréal, but the clan also has little incentive to sell its 112-year-old group at a major discount to that level.
Experts suggest the Spanish group may seek to retain influence in any combined entity, potentially forcing Estée Lauder to offer a premium valuation and a substantial equity component.
“This all points to a poor deal, from the perspective of Estée’s minority shareholders. Assume a 20% premium to Puig’s Monday closing level, and the purchase price including net debt would be $13 billion,” said Yawen Chen, columnist at Reuters.
Analysts at Jefferies said potential synergies from the deal could amount to about 6% of Puig’s sales annually, or roughly $380 million.
When combined with Puig’s projected 2029 operating profit, based on Visible Alpha estimates, and adjusted for a 25% tax rate, the total return to Estée Lauder after three years would be around $1.1 billion.
This equates to an estimated return of 8.7% on the assumed purchase price, falling short of the target company’s weighted average cost of capital of 9%, according to Jefferies.
Balance sheet pressures add to risks
Financing the deal could also stretch Estée Lauder’s balance sheet.
JPMorgan analysts estimate that a deal financed through an equal mix of equity and debt would require Estée Lauder to take on roughly $6 billion in additional borrowing.
This could lift its leverage to around 4.3 times, even before any potential synergies from the transaction are realised, they said in a note.
Credit ratings agencies Moody’s and S&P Global both assign the US company a negative outlook.
Deal could boost Estée Lauder against L’Oréal
Despite the risks, the strategic logic behind the deal is clear.
A merger would strengthen Estée Lauder’s position in fragrances, one of the fastest-growing segments in the beauty industry.
Rival L’Oréal has been expanding aggressively in this space, including its acquisition of Kering’s beauty division, which added premium brands and long-term licensing agreements.
Fragrance sales at L’Oréal have outpaced the broader market, growing 10.4% in 2025, highlighting the segment’s resilience and growth potential.
Estée Lauder has also benefited from strong demand in fragrances, even as other parts of its business have faced pressure.
By combining with Puig, the US company would gain access to a portfolio of well-established perfume and fashion brands, enhancing its ability to compete more effectively with its French rival.
“Estee Lauder’s potential acquisition of Puig would give the US beauty giant greater strength to compete with its French rival L’Oreal, Bernstein analysts say in a note.
“A takeover of Puig would give Estee Lauder well-known perfume and fashion brands such as Rabanne, Jean Paul Gaultier, and Carolina Herrera, helping it compete better against L’Oreal,” Bernstein says.
Analysts say a successful merger could create a more formidable competitor in the global beauty market, particularly in the premium fragrance category.
The post Why is Estée Lauder's stock falling on talks of merger with Spain's Puig? appeared first on Invezz
